Other
BRCA1/2 Mutation
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
BRCA1/2 Mutation is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Terminated1 · 33%
Unknown status1 · 33%
Active, not recruiting1 · 33%
Clinical Trials
Trial Activity
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Active, not recruiting·—·Phase 1·NCT04367675·44 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)